Header cover image

U.S. Healthcare Sector Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies1565
  • 7D1.6%
  • 3M5.7%
  • 1Y-8.7%
  • YTD-10.9%

In the last week, the Healthcare industry is up 1.6%, with Merck leading the way with a 3.1% gain. Meanwhile, BeiGene actually underperformed within the industry, shrinking 14% in the last week. In contrast, the industry has lost 8.7% in the last 12 months. Looking forward, earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 29 Nov 2022US$6.0tUS$2.4tUS$133.6b24.1x45.1x2.5x
Thu, 27 Oct 2022US$5.8tUS$2.4tUS$157.4b22.8x37.1x2.4x
Sat, 24 Sep 2022US$5.5tUS$2.4tUS$155.9b20.7x35.4x2.3x
Mon, 22 Aug 2022US$6.0tUS$2.4tUS$157.0b24x38.4x2.5x
Wed, 20 Jul 2022US$5.9tUS$2.6tUS$165.3b24.9x35.8x2.3x
Fri, 17 Jun 2022US$5.4tUS$2.6tUS$165.3b22.8x32.4x2.1x
Sun, 15 May 2022US$5.7tUS$2.6tUS$164.8b25x34.9x2.2x
Tue, 12 Apr 2022US$6.5tUS$2.5tUS$174.7b29.4x37.5x2.6x
Thu, 10 Mar 2022US$6.2tUS$2.5tUS$171.0b28.1x36.1x2.5x
Sat, 05 Feb 2022US$6.3tUS$2.4tUS$165.0b29.7x38.2x2.6x
Mon, 03 Jan 2022US$6.9tUS$2.4tUS$145.5b32.9x47.5x2.9x
Wed, 01 Dec 2021US$6.6tUS$2.4tUS$146.5b30.6x44.8x2.7x
Fri, 29 Oct 2021US$6.8tUS$2.3tUS$127.3b34x53.2x2.9x
Sun, 26 Sep 2021US$6.9tUS$2.3tUS$120.1b36.1x57.2x3x
Tue, 24 Aug 2021US$6.9tUS$2.3tUS$121.2b33.3x57.2x3x
Wed, 30 Jun 2021US$6.6tUS$2.3tUS$113.6b32.4x57.7x2.9x
Sat, 03 Apr 2021US$6.0tUS$2.4tUS$93.5b29x64.1x2.5x
Tue, 05 Jan 2021US$5.8tUS$2.3tUS$87.0b29.3x66.5x2.5x
Fri, 09 Oct 2020US$5.1tUS$2.3tUS$104.6b28.7x49.1x2.3x
Thu, 02 Jul 2020US$4.8tUS$2.4tUS$101.2b31.4x47.4x2x
Sun, 05 Apr 2020US$3.9tUS$2.4tUS$99.2b28.8x39x1.6x
Wed, 08 Jan 2020US$4.5tUS$2.3tUS$100.0b29.1x44.5x1.9x
Price to Earnings Ratio

46.5x


Total Market Cap: US$4.3tTotal Earnings: US$92.9bTotal Revenue: US$2.2tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 48.1x202020212022
Current Industry PE
  • Investors are relatively neutral on the American Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 48.1x.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 13% per year over the last three years.
  • Revenues for these companies have grown 2.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market1.26%
Healthcare1.63%
Life Sciences2.40%
Healthcare Services2.14%
Medical Equipment1.91%
Pharma1.59%
Healthtech0.53%
Biotech0.44%
Industry PE
  • Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 9.4%, which is lower than the prior year's growth of 60.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 36% over the next 5 years.
  • This is better than its past earnings growth rate of 28% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 9.4% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UNH UnitedHealth GroupUS$532.272.9%
+US$14.1b
17.8%PE25.6x
PFE PfizerUS$49.572.9%
+US$7.8b
-5.4%PE9.3x
MRK MerckUS$108.452.7%
+US$7.2b
44.8%PE17.9x
LLY Eli LillyUS$365.771.3%
+US$4.4b
43.5%PE57.6x
JNJ Johnson & JohnsonUS$177.330.8%
+US$3.6b
11.0%PE24.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

UNH

US$532.27

UnitedHealth Group

7D

2.9%

1Y

17.8%

MDT

US$76.13

Medtronic

7D

-7.5%

1Y

-31.0%

BIIB

US$291.90

Biogen

7D

-3.2%

1Y

23.6%

PFE

US$49.57

Pfizer

7D

2.9%

1Y

-5.4%

BGNE

US$179.29

BeiGene

7D

-7.9%

1Y

-47.8%

ABT

US$105.39

Abbott Laboratories

7D

1.5%

1Y

-17.7%

ILMN

US$216.91

Illumina

7D

-3.3%

1Y

-41.5%

AMGN

US$282.62

Amgen

7D

-1.9%

1Y

38.9%

MRNA

US$175.38

Moderna

7D

-0.8%

1Y

-52.4%

NVCR

US$70.06

NovoCure

7D

-7.0%

1Y

-24.9%

JNJ

US$177.33

Johnson & Johnson

7D

0.8%

1Y

11.0%